StockData
PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) stock

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.42−0.15 (-2.69%)

Close on Nov 17, 2026Market cap $58.19MP/E –Yield –

PharmaCyte Biotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

PharmaCyte Biotech's price to sales ratio was 312.3× on Jan 31, 2013.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2013Jan 31, 2013312.3×–

More PharmaCyte Biotech figures

See a number that looks wrong?